Literature DB >> 2307982

Selective disconnection of specific visual association pathways in cases of Alzheimer's disease presenting with Balint's syndrome.

P R Hof1, C Bouras, J Constantinidis, J H Morrison.   

Abstract

During a recent clinical and neuropathological evaluation of a large autopsy population of brains our attention was drawn to a subset of patients with Alzheimer's disease (AD) presenting with a major impairment of visuospatial skills referred to as Balint's syndrome. In this subset a shift in the distribution of certain pathological profiles had occurred in that the visual areas of the occipital and posterior parietal regions had an increased number of lesions, whereas the prefrontal cortex had fewer lesions than usually observed in AD. Previous quantitative analyses have shown that generally in AD, primary sensory cortical areas are less damaged than association areas of the frontal and temporal lobes, as demonstrated by the laminar and regional distribution of two neuropathological features of the disease, neurofibrillary tangles and neuritic (senile) plaques. The distribution of pathological lesions in the AD cases with Balint's syndrome revealed that specific visual association pathways were disrupted, which are normally spared in AD. These data suggest that in some cases of AD, the particular psychological and neurological symptomatology may be caused by the selective loss of specific corticocortical systems, as reflected in the differential distribution of the neuropathological markers of the disease.

Entities:  

Mesh:

Year:  1990        PMID: 2307982     DOI: 10.1097/00005072-199003000-00008

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  45 in total

Review 1.  Psychoanatomical substrates of Bálint's syndrome.

Authors:  M Rizzo; S P Vecera
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

2.  A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease.

Authors:  P G Vallet; R Guntern; P R Hof; J Golaz; A Delacourte; N K Robakis; C Bouras
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  Amyloid imaging in dementias with atypical presentation.

Authors:  David A Wolk; Julie C Price; Charles Madeira; Judy A Saxton; Beth E Snitz; Oscar L Lopez; Chester A Mathis; William E Klunk; Steven T DeKosky
Journal:  Alzheimers Dement       Date:  2012-01-30       Impact factor: 21.566

Review 4.  [The clinical syndrome of posterior cortical atrophy].

Authors:  E Karner; C Jenner; E Donnemiller; M Delazer; T Benke
Journal:  Nervenarzt       Date:  2006-02       Impact factor: 1.214

5.  Disorders of learning and memory processes in a monkey model of Alzheimer's disease: the role of the associative area of the cerebral cortex.

Authors:  K N Dudkin; I V Chueva; F N Makarov; T G Bich; A E Roher
Journal:  Neurosci Behav Physiol       Date:  2006-10

6.  Visual discrimination predicts naming and semantic association accuracy in Alzheimer disease.

Authors:  Stacy M Harnish; Jean Neils-Strunjas; James Eliassen; Jamie Reilly; Marcus Meinzer; John Greer Clark; Jane Joseph
Journal:  Cogn Behav Neurol       Date:  2010-12       Impact factor: 1.600

7.  Posterior cortical atrophy: Unique features.

Authors:  T Tom; J L Cummings; J Pollak
Journal:  Neurocase       Date:  1998-01       Impact factor: 0.881

8.  Myelinated axon number in the optic nerve is unaffected by Alzheimer's disease.

Authors:  D C Davies; P McCoubrie; B McDonald; K A Jobst
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

Review 9.  Posterior Cortical Atrophy.

Authors:  Jonathan M Schott; Sebastian J Crutch
Journal:  Continuum (Minneap Minn)       Date:  2019-02

Review 10.  Where am I and how will I get there from here? A role for posterior parietal cortex in the integration of spatial information and route planning.

Authors:  Jeffrey L Calton; Jeffrey S Taube
Journal:  Neurobiol Learn Mem       Date:  2008-11-12       Impact factor: 2.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.